Category: Include on Menu
-
Four Leaf Acquisition and Data443 Advance Business Combination Toward Planned Nasdaq Listing
Four Leaf Acquisition (USOTC:FORL) and Data443 Risk Mitigation (USOTC:ATDS) are advancing their definitive business combination, with preparation of a Form S-4 underway as the companies pursue a Nasdaq listing for the combined business, subject to required approvals and closing conditions. Key Investor Takeaways Why FORL and ATDS Stocks Are in Focus Four Leaf and Data443…
-
Medical Care Technologies Advances Melanoma Scan Beta for AI-Assisted Skin Monitoring
Medical Care Technologies (USOTC:MDCE) is advancing its Melanoma Scan Beta, an AI-assisted imaging platform designed to help users track visible skin changes over time, while the product remains in beta development without regulatory clearance. Key Investor Takeaways Why MDCE Stock Is in Focus Medical Care Technologies is continuing development of Melanoma Scan Beta, positioning the…
-
InterDigital Third Disney Injunction Strengthens European Patent Enforcement Position
InterDigital (NASDAQ:IDCC) has secured a third Disney (NYSE:DIS) injunction from the Unified Patent Court, extending its record of successful patent enforcement against the entertainment group and reinforcing the importance of its video technology licensing portfolio. Key Investor Takeaways Why IDCC Stock Is in Focus InterDigital’s latest Disney injunction adds another favourable ruling to its ongoing…
-
Halozyme Investor Conferences Put ENHANZE and Expanded Drug Delivery Portfolio in Focus
Halozyme (NASDAQ:HALO) will participate in three healthcare investor conferences during September, giving management multiple opportunities to discuss its commercially validated ENHANZE platform and expanding portfolio of drug delivery technologies. Key Investor Takeaways Why HALO Stock Is in Focus Halozyme President and Chief Executive Officer Helen Torley and Chief Financial Officer Darren Snellgrove are scheduled to…
-
RenovoRx H.C. Wainwright Presentation to Highlight RenovoCath Growth and Phase III TIGeR-PaC Timeline
RenovoRx (NASDAQ:RNXT) will use its H.C. Wainwright presentation to update investors on growing RenovoCath commercial demand, recent clinical evidence and the timeline toward Phase III TIGeR-PaC data. Key Investor Takeaways Why RNXT Stock Is in Focus RenovoRx Chief Executive Shaun Bagai and Chief Financial Officer Mark Voll are scheduled to present at the H.C. Wainwright…
-
U.S. Factory Orders Rise 0.9%, Exceeding Expectations
U.S. factory orders increased 0.9% in the latest reporting period, exceeding economists’ expectations and reversing the decline recorded in the previous month. Economists had forecast an increase of 0.7%, while factory orders had fallen 0.2% in the preceding period. Factory orders measure the total value of new purchase orders placed with U.S. manufacturers and include…
-
Caterpillar Collaborates With FieldAI on Industrial Robotics and AI Technology
Caterpillar Inc. (NYSE:CAT) announced a collaboration with FieldAI focused on deploying artificial intelligence, robotics and digital twin technology across industrial jobsites and manufacturing facilities. The collaboration combines Caterpillar’s operational data and engineering capabilities with FieldAI’s robot-agnostic autonomy software and foundation models. According to Caterpillar, initial applications include autonomous inspections, real-time digital twins of facilities, situational…
-
REX American Resources Shares Fall 4.6% After Mixed Fiscal Q2 Results
REX American Resources Corporation (NYSE:REX) shares fell 4.6% following the release of fiscal second-quarter 2026 results that exceeded analyst earnings expectations but came in below the consensus revenue forecast. The ethanol producer reported adjusted earnings per share of $1.06, compared with an analyst estimate of $0.42. Revenue reached $168.5 million, below the consensus estimate of…
-
PACS Group Shares Rise 3.3% as Company Plans Florida Expansion and Completes More Eduro Acquisitions
PACS Group, Inc. (NYSE:PACS) shares rose 3.3% in premarket trading on Wednesday after the company announced definitive agreements to acquire the operations of 32 skilled nursing facilities in Florida and completed additional facility acquisitions from Eduro Healthcare. The Florida facilities comprise 4,049 licensed skilled nursing beds and will be leased from Omega Healthcare Investors, Inc.…
-
Telix Pharmaceuticals Shares Rise 5.3% as Analyst Highlights BiPASS Trial and FDA Pathway
Telix Pharmaceuticals Ltd ADR (NASDAQ:TLX) shares rose 5.3% in premarket trading on Wednesday as investors assessed the company’s Phase 3 BiPASS trial progress and its regulatory pathway in the U.S. H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Telix and maintained a $20.00 price target after the company completed enrollment in the BiPASS…